HARRISON F. FLIPPIN, M.D., F.A.C.P.; JOHN G. REINHOLD, Ph.D.; LILLIAN POLLACK; ELAINE CLAUSEN, B.A.
This content is PDF only. Please click on the PDF icon to access.
Renal complications due to sulfonamide therapy continue to be among the most frequent and serious attending the use of these drugs.1, 2, 3 Two main causes are established: (1) irritation due to formation in the kidneys or ureters of crystals largely of the acetylated drug and (2) nephrotoxic action. The causes of the latter are poorly understood. However, there is ample evidence to show that crystalluria is the result of the very low solubility of the acetylated drugs in urine that is acid in reaction.4, 5, 6, 7, 8 Despite numerous demonstrations of the effectiveness of alkalinization6, 9, 10, 11,
FLIPPIN HF, REINHOLD JG, POLLACK L, et al. AN EVALUATION OF SULFONAMIDE MIXTURES AND VARIOUS ADJUVANTS FOR CONTROL OF SULFONAMIDE CRYSTALLURIA*. Ann Intern Med. 1946;25:433–442. doi: https://doi.org/10.7326/0003-4819-25-3-433
Download citation file:
Published: Ann Intern Med. 1946;25(3):433-442.
Hospital Medicine, Infectious Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use